Suppr超能文献

CT扫描显示胃及胃食管腺癌的隐匿性淋巴结

CT Scans Understage Lymph Nodes in Gastric and Gastroesophageal Adenocarcinoma.

作者信息

Pettigrew Morgan F, Kumar Priya, Nahi Skylar L, Reznik Scott I, Hammer Suntrea T G, Porembka Matthew R, Wang Sam C

机构信息

Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

J Surg Oncol. 2025 Jun;131(8):1571-1579. doi: 10.1002/jso.28112. Epub 2025 Mar 28.

Abstract

BACKGROUND AND OBJECTIVES

The presence of lymph node metastases in patients with gastric and gastroesophageal junction (GEJ) adenocarcinoma provides prognostic information and guides treatment decisions. We sought to determine the sensitivity of computed tomography (CT) imaging for clinical nodal staging in patients with resectable gastric and GEJ adenocarcinoma and determine a lymph node size cut-off to optimize diagnostic accuracy.

METHODS

We performed a retrospective review of patients who underwent curative-intent resection for gastric or GEJ adenocarcinoma at our institution between 2010 and 2023. We reviewed CT scan images performed immediately before resection and measured lymph nodes in the short axis to identify patients with lymph nodes larger than the radiologic upper limit of normal. We compared histopathologic data from resection specimens to CT scans to determine pathologic concordance for metastatic involvement of lymph nodes and calculated the sensitivity and specificity of CT scans to identify nodal metastases. We used the largest lymph node measurement from each scan to construct a receiver operating characteristic (ROC) curve and calculated Youden's J Index to determine the optimal lymph node size cut-off.

RESULTS

We identified 192 consecutive patients who underwent resection during the study period and had preoperative CT scans available for review. 72 patients (38%) had diffuse or mixed type tumors, and 85 patients (44%) had intestinal-type tumors. 157 patients (82%) underwent neoadjuvant chemotherapy or chemoradiation. 110 patients (57%) had pathologic node-positive disease and in this cohort, 27 patients (25%) had lymph nodes deemed radiographically enlarged. The sensitivity of preoperative CT scans for nodal metastases was 25%, and specificity was 83%. Based on the ROC curve, an optimal lymph node size cutoff of 6.5 mm was identified. At this cutoff, the estimated sensitivity was 47%, and the estimated specificity was 72%. When patients were stratified by Lauren histology, the AUC for intestinal-type tumors was significantly better than for diffuse or mixed-type tumors (p = 0.02). The area under the ROC curve for patients with diffuse or mixed type tumors was 0.51 indicating lymph node size on CT scan was no better than random chance for diagnosis of lymph node metastases.

CONCLUSIONS

CT scans are not sensitive to identify nodal metastases in gastric and GEJ adenocarcinoma using current radiologic guidelines. While a lower lymph node size cutoff may improve sensitivity, this does not benefit patients with diffuse or mixed-type tumors. Since CT scans understage a large proportion of patients with gastric and GEJ cancers, techniques to improve clinical nodal staging in this population are needed.

摘要

背景与目的

胃及胃食管交界(GEJ)腺癌患者出现淋巴结转移可提供预后信息并指导治疗决策。我们试图确定计算机断层扫描(CT)成像对可切除胃及GEJ腺癌患者临床淋巴结分期的敏感性,并确定淋巴结大小的临界值以优化诊断准确性。

方法

我们对2010年至2023年间在本机构接受胃或GEJ腺癌根治性切除的患者进行了回顾性研究。我们回顾了切除术前立即进行的CT扫描图像,并测量了淋巴结的短轴,以确定淋巴结大于正常影像学上限的患者。我们将切除标本的组织病理学数据与CT扫描进行比较,以确定淋巴结转移的病理一致性,并计算CT扫描识别淋巴结转移的敏感性和特异性。我们使用每次扫描中最大的淋巴结测量值构建受试者操作特征(ROC)曲线,并计算约登指数以确定最佳淋巴结大小临界值。

结果

我们确定了192例在研究期间接受切除且有术前CT扫描可供回顾的连续患者。72例(38%)患者为弥漫型或混合型肿瘤,85例(44%)患者为肠型肿瘤。157例(82%)患者接受了新辅助化疗或放化疗。110例(57%)患者有病理淋巴结阳性疾病,在该队列中,27例(25%)患者的淋巴结在影像学上被认为增大。术前CT扫描对淋巴结转移的敏感性为25%,特异性为83%。根据ROC曲线,确定最佳淋巴结大小临界值为6.5毫米。在此临界值时,估计敏感性为47%,估计特异性为72%。当根据劳伦组织学对患者进行分层时,肠型肿瘤的ROC曲线下面积显著优于弥漫型或混合型肿瘤(p = 0.02)。弥漫型或混合型肿瘤患者的ROC曲线下面积为0.51,表明CT扫描上的淋巴结大小在诊断淋巴结转移方面并不比随机猜测更好。

结论

根据当前影像学指南,CT扫描对识别胃及GEJ腺癌的淋巴结转移不敏感。虽然较低的淋巴结大小临界值可能提高敏感性,但这对弥漫型或混合型肿瘤患者无益。由于CT扫描使很大一部分胃及GEJ癌患者的分期偏低,因此需要改进该人群临床淋巴结分期的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3da/12232095/834e6e81d639/JSO-131-1571-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验